Author(s):
Tarantini, Giuseppe ; Tang, Gilbert ; Nai Fovino, Luca ; Blackman, Daniel ; Van Mieghem, Nicolas M ; Kim, Won-Keun ; Karam, Nicole ; Carrilho-Ferreira, Pedro ; Fournier, Stephane ; Pręgowski, Jerzy ; Fraccaro, Chiara ; Vincent, Flavien ; Campante Teles, Rui ; Mylotte, Darren ; Wong, Ivan ; Bieliauskas, Gintautas ; Czerny, Martin ; Bonaros, Nikolaos ; Parolari, Alessandro ; Dudek, Darius ; Tchétché, Didier ; Eltchaninoff, Hélène ; de Backer, Ole ; Stefanini, Giulio ; Sondergaard, Lars
Date: 2023
Persistent ID: http://hdl.handle.net/10362/150475
Origin: Repositório Institucional da UNL
Subject(s): aortic stenosis; coronary artery disease; TAVI; Cardiology and Cardiovascular Medicine; SDG 3 - Good Health and Well-being
Description
Significant coronary artery disease (CAD) is a frequent finding in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI), and the management of these two conditions becomes of particular importance with the extension of the procedure to younger and lower-risk patients. Yet, the preprocedural diagnostic evaluation and the indications for treatment of significant CAD in TAVI candidates remain a matter of debate. In this clinical consensus statement, a group of experts from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the European Society of Cardiology (ESC) Working Group on Cardiovascular Surgery aims to review the available evidence on the topic and proposes a rationale for the diagnostic evaluation and indications for percutaneous revascularisation of CAD in patients with severe aortic stenosis undergoing transcatheter treatment. Moreover, it also focuses on commissural alignment of transcatheter heart valves and coronary re-access after TAVI and redo-TAVI.
